Table 3 Clinical characteristics of kidney receptors
Donor | uEV Analysis | Cold ischemia (hours) | Mismatch | Recipient’s previous KTx | DSA | IS | Delay Graft function | ACR | CHR | KB | Days until stable Renal function | SrCr (mg/dL) 1 year After KTx | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A | B | DR | ||||||||||||
LD1 | P, T | 2 | 0 | 0 | 0 | 1 | – | P, B, FK, MMf | – | – | – | – | 5 | 1 |
LD2 | P, T | 2 | 1 | 1 | 1 | – | – | P, B, FK, MMf | – | – | – | – | 6 | 1.2 |
LD3 | P, T | 2 | 1 | 1 | 2 | – | – | P, B, FK, MMf | – | – | – | – | 8 | 1.14 |
LD4 | P, T | 2 | 1 | 1 | 1 | – | – | P, B, FK, MMf | Yes | Yes | – | ACR | – | – |
LD5 | P, T | 4 | 1 | 2 | 1 | – | – | P, B, FK, MMf | ||||||
DD1 | P, T | 20 | 2 | 2 | 1 | – | – | P, FK, MMf | – | – | – | – | 14 | 1,82 |
Not transplanted | ||||||||||||||
DD2 | P,T | 18 | 2 | 2 | 1 | – | – | P, B, FK, MMf | – | – | – | – | 20 | 1.77 |
22 | 0 | 0 | 1 | – | – | P, B, FK, MMf | – | – | – | – | 15 | 1.23 | ||
DD3 | P,T | 18 | 1 | 1 | 1 | – | – | P, FK, Th, Everolimus | – | – | – | – | 7 | 1.45 |
Not transplanted | ||||||||||||||
DD4 | T | 20 | 1 | 1 | 1 | – | – | P, B, FK, MMf | – | – | – | CNTI | 15 | 1.67 |
15 | 1 | 2 | 1 | – | – | P, B, FK, MMf | – | – | – | ATN, TAIF | 6 | 2.6 | ||
DD5 | T | 20 | 1 | 2 | 2 | – | – | P, B, FK, MMf | – | – | – | – | 9 | 1.64 |
17 | 1 | 1 | 1 | – | – | Eculizumab, P, FK, MMF, Th | – | – | – | – | 24 | 1.39 | ||
DD6 | P | 13 | 2 | 2 | 1 | – | – | P, B, FK, MMf | – | Yes | – | ACR | 24 | 1.03 |
22 | 1 | 1 | 1 | – | Yes | P,FK; MMf, Th | – | – | – | – | 25 | 1.16 | ||
DD7 | P | 17 | 2 | 2 | 1 | – | – | P, B, FK, MMf | Yes | – | – | – | 30 | 1.01 |
20 | 1 | 1 | 1 | – | – | P, B, FK, MMf | – | – | – | – | 30 | 1.01 | ||